CVS Health Co. (NYSE:CVS) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of CVS Health Co. (NYSE:CVS) have been given an average rating of “Moderate Buy” by the nineteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $69.12.

CVS has been the topic of a number of analyst reports. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $60.00 to $66.00 in a research note on Monday, November 18th. Royal Bank of Canada lowered their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. Piper Sandler decreased their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. Truist Financial restated a “buy” rating and set a $67.00 price target (down from $76.00) on shares of CVS Health in a research report on Wednesday, November 20th. Finally, Evercore ISI increased their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th.

CVS Health Stock Up 0.2 %

Shares of NYSE CVS opened at $44.25 on Wednesday. The business’s fifty day moving average price is $55.80 and its 200-day moving average price is $58.10. CVS Health has a one year low of $43.56 and a one year high of $83.25. The stock has a market capitalization of $55.68 billion, a PE ratio of 11.23, a P/E/G ratio of 0.85 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company’s revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the company earned $2.21 earnings per share. On average, equities research analysts anticipate that CVS Health will post 5.32 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. State Street Corp grew its position in CVS Health by 3.6% during the 3rd quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator’s stock worth $3,554,475,000 after acquiring an additional 1,989,066 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of CVS Health by 1.8% in the third quarter. Geode Capital Management LLC now owns 26,361,673 shares of the pharmacy operator’s stock worth $1,651,997,000 after buying an additional 461,569 shares during the period. Pzena Investment Management LLC raised its holdings in CVS Health by 1.5% during the 3rd quarter. Pzena Investment Management LLC now owns 13,135,308 shares of the pharmacy operator’s stock valued at $825,948,000 after buying an additional 198,920 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in CVS Health by 2.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 12,208,668 shares of the pharmacy operator’s stock valued at $767,681,000 after buying an additional 304,386 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC increased its position in shares of CVS Health by 34.8% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator’s stock valued at $748,085,000 after acquiring an additional 3,071,613 shares during the period. 80.66% of the stock is owned by institutional investors.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.